An Imaging Framework for Clinically Testing New Treatments to Prevent Post-traumatic OA
Launched by J L MARSH · Jan 16, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into a new kind of imaging technology called a standing CT scanner to help detect early signs of joint problems, specifically after ankle fractures. The goal is to see if this low-cost and low-dose scanner can find changes in the joints or stress on them before other imaging methods can. This early detection could help doctors decide on the best treatments and also identify which patients are at higher risk for developing osteoarthritis, a type of joint pain that can happen after injuries.
To be eligible for this trial, participants need to be between 18 and 70 years old and have recently experienced a specific type of ankle fracture that requires surgery. If you join the study, you'll undergo imaging tests using the new standing CT scanner, and your results may help improve future treatments for patients with similar injuries. It's important to note that pregnant women and those outside the age range cannot participate. If you're interested in learning more or think you might qualify, this could be an opportunity to contribute to important research that may benefit others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals 18 to 70 years old Sustained an intra-articular fracture of the tibial plafond Indicated for operative treatment Present for treatment within 4 weeks of injury
- Exclusion Criteria:
- • Women who are pregnant or planning on becoming pregnant Individuals younger than 18 and older than 70
About J L Marsh
J L Marsh is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on integrity and scientific excellence, the organization collaborates with healthcare professionals and research institutions to design and implement trials that adhere to the highest regulatory standards. J L Marsh emphasizes patient safety and ethical considerations while exploring new treatments and therapies across various therapeutic areas. Through its rigorous approach to clinical research, J L Marsh aims to contribute valuable insights that drive medical advancements and enhance healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Iowa City, Iowa, United States
Patients applied
Trial Officials
J L Marsh, MD
Principal Investigator
University of Iowa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials